Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

9.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.6K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Activation Energy01:26

Activation Energy

86.7K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.7K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

11.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An essential role for the Zn<sup>2+</sup> transporter ZIP7 in B cell development.

Nature immunology·2019
Same author

Hyper IgM Syndrome: a Report from the USIDNET Registry.

Journal of clinical immunology·2016
Same author

Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.

Journal of clinical immunology·2015
Same author

CD19 controls Toll-like receptor 9 responses in human B cells.

The Journal of allergy and clinical immunology·2015
Same author

The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.

Journal of clinical immunology·2015
Same author

Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency.

Journal of clinical immunology·2015
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Related Experiment Video

Updated: Feb 6, 2026

Protein Modifications: Protein Kinases and Phosphatases
02:54

Protein Modifications: Protein Kinases and Phosphatases

15.2K

Genes required for B cell development.

Mary Ellen Conley1

  • 1Department of Immunology, St. Judes Children's Research Hospital, Memphis, Tennessee 38105, USA. maryellen.conely@stjude.org

The Journal of Clinical Investigation
|December 9, 2003
PubMed
Summary
This summary is machine-generated.

Congenital agammaglobulinemia is linked to gene mutations affecting B cell development. A new gene, LRRC8, identified through a patient translocation, causes a similar B cell differentiation block.

More Related Videos

Regulated and Targeted Protein Degradation
02:58

Regulated and Targeted Protein Degradation

8.9K
Covalently Linked Protein Regulators and Post-translational Modification
02:04

Covalently Linked Protein Regulators and Post-translational Modification

9.6K

Related Experiment Videos

Last Updated: Feb 6, 2026

Protein Modifications: Protein Kinases and Phosphatases
02:54

Protein Modifications: Protein Kinases and Phosphatases

15.2K
Regulated and Targeted Protein Degradation
02:58

Regulated and Targeted Protein Degradation

8.9K
Covalently Linked Protein Regulators and Post-translational Modification
02:04

Covalently Linked Protein Regulators and Post-translational Modification

9.6K

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Congenital agammaglobulinemia results from genetic defects impairing B cell development.
  • Known genetic causes involve components of the pre-B cell receptor or its signaling pathway.
  • These defects typically cause a differentiation block at the pro-B to pre-B cell stage.

Purpose of the Study:

  • To investigate the genetic basis of a specific case of congenital agammaglobulinemia.
  • To identify novel genes involved in B cell development and differentiation.
  • To understand the molecular mechanisms underlying B cell development blocks.

Main Methods:

  • Analysis of a patient with a chromosomal translocation.
  • Gene identification through molecular genetic techniques.
  • Characterization of B cell differentiation stages in the patient.

Main Results:

  • A translocation involving the previously uncharacterized gene LRRC8 was identified in the patient.
  • This genetic alteration resulted in a block in B cell differentiation at the pro-B to pre-B cell transition, mirroring known genetic defects.
  • The identified gene LRRC8 is implicated in the B cell development pathway.

Conclusions:

  • The LRRC8 gene plays a critical role in normal B cell differentiation.
  • Defects in LRRC8 can cause congenital agammaglobulinemia by blocking B cell development.
  • Further research is needed to elucidate LRRC8's precise role in the pre-B cell receptor signaling pathway or novel pathways.